8.60
Precedente Chiudi:
$8.49
Aprire:
$8.25
Volume 24 ore:
139.79K
Relative Volume:
2.06
Capitalizzazione di mercato:
$186.59M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+3.61%
1M Prestazione:
-31.47%
6M Prestazione:
-24.43%
1 anno Prestazione:
+0.00%
Aardvark Therapeutics Inc Stock (AARD) Company Profile
Nome
Aardvark Therapeutics Inc
Settore
Industria
Telefono
(858) 225-7696
Indirizzo
4370 LA JOLLA VILLAGE DRIVE, SAN DIEGO
Confronta AARD con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
AARD
Aardvark Therapeutics Inc
|
8.60 | 184.17M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Aardvark Therapeutics Inc Stock (AARD) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-06-30 | Iniziato | H.C. Wainwright | Buy |
2025-03-10 | Iniziato | BofA Securities | Buy |
2025-03-10 | Iniziato | Cantor Fitzgerald | Overweight |
2025-03-10 | Iniziato | Morgan Stanley | Overweight |
2025-03-10 | Iniziato | RBC Capital Mkts | Outperform |
Aardvark Therapeutics Inc Borsa (AARD) Ultime notizie
Aardvark Therapeutics Inc. stock daily chart insights2025 Top Decliners & AI Optimized Trading Strategy Guides - Newser
Will Aardvark Therapeutics Inc. stock go up soonJuly 2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - Newser
Published on: 2025-09-07 01:45:43 - Newser
Can Aardvark Therapeutics Inc. recover in the next quarterTrend Reversal & AI Forecast Swing Trade Picks - Newser
Developing predictive dashboards with Aardvark Therapeutics Inc. dataEarnings Miss & Breakout Confirmation Alerts - Newser
How to forecast Aardvark Therapeutics Inc. trends using time seriesTrade Entry Summary & Advanced Swing Trade Entry Plans - Newser
What high frequency data says about Aardvark Therapeutics Inc.Dollar Strength & High Conviction Investment Ideas - Newser
Can volume confirm reversal in Aardvark Therapeutics Inc.2025 Historical Comparison & AI Driven Stock Movement Reports - Newser
What MACD signals say about Aardvark Therapeutics Inc.July 2025 Breakouts & Fast Gain Swing Alerts - Newser
Candlestick signals on Aardvark Therapeutics Inc. stock todayBull Run & Weekly High Momentum Picks - Newser
Aardvark Therapeutics Inc. stock chart pattern explainedOil Prices & Free Technical Pattern Based Buy Signals - Newser
Real time breakdown of Aardvark Therapeutics Inc. stock performanceJuly 2025 Opening Moves & Verified Chart Pattern Signals - Newser
Custom watchlist performance reports with Aardvark Therapeutics Inc.Sell Signal & Precise Swing Trade Entry Alerts - Newser
Is Aardvark Therapeutics Inc. a candidate for recovery play2025 Dividend Review & Free High Accuracy Swing Entry Alerts - Newser
Is Aardvark Therapeutics Inc. stock a smart retirement pickEarnings Recap Summary & Safe Capital Growth Plans - خودرو بانک
Will Aardvark Therapeutics Inc. stock recover after earningsJuly 2025 Technicals & Community Consensus Stock Picks - خودرو بانک
Does Aardvark Therapeutics Inc. offer margin of safetyJuly 2025 Update & Capital Efficiency Focused Ideas - خودرو بانک
Statistical indicators supporting Aardvark Therapeutics Inc.’s strengthOil Prices & Consistent Growth Equity Picks - Newser
How to build a custom watchlist for Aardvark Therapeutics Inc.July 2025 Levels & Real-Time Stock Movement Alerts - Newser
Is Aardvark Therapeutics Inc. stock showing strong momentum2025 Sector Review & Expert-Curated Trade Recommendations - خودرو بانک
What’s next for Aardvark Therapeutics Inc. stock priceJuly 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - Newser
Aardvark Therapeutics reports inducement grants under Nasdaq listing rule - TipRanks
Will Aardvark Therapeutics Inc. bounce back from current supportJuly 2025 Intraday Action & Daily Stock Trend Reports - Newser
Aardvark Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Can machine learning forecast Aardvark Therapeutics Inc. recoveryMarket Performance Recap & Stock Portfolio Risk Management - Newser
Tick level data insight on Aardvark Therapeutics Inc. volatilityPortfolio Gains Report & Risk Controlled Daily Plans - Newser
Tools to assess Aardvark Therapeutics Inc.’s risk profileJuly 2025 Sector Moves & Breakout Confirmation Alerts - Newser
Is Aardvark Therapeutics Inc. stock overvalued or fairly pricedJuly 2025 Summary & Verified Entry Point Detection - خودرو بانک
Aardvark Therapeutics (AARD): Pioneering Gut-Brain Signaling to Disrupt Obesity and Metabolic Disease Therapies - AInvest
Aardvark Therapeutics’ Strategic Position in Metabolic Disease Innovation - AInvest
Should you buy the dip on Aardvark Therapeutics Inc.July 2025 Rallies & Expert-Curated Trade Recommendations - خودرو بانک
Combining machine learning predictions for Aardvark Therapeutics Inc.Gold Moves & Verified Momentum Stock Alerts - Newser
Aardvark Therapeutics Updates Corporate Presentation on Strategy - TipRanks
Can Aardvark Therapeutics Inc. continue delivering strong returns2025 Dividend Review & Trade Opportunity Analysis Reports - خودرو بانک
Aardvark Therapeutics Inc Azioni (AARD) Dati Finanziari
Non sono disponibili dati finanziari per Aardvark Therapeutics Inc (AARD). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):